US 8481731
Compounds, pharmaceutical composition and methods relating thereto
granted A61PA61P1/18A61P19/02
Quick answer
US patent 8481731 (Compounds, pharmaceutical composition and methods relating thereto) held by Neurocrine Biosciences, Inc. expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P1/18, A61P19/02, A61P19/10, A61P25/00